NASDAQ
NextCure, Inc. (NXTC) has a free cash flow growth of -74.95% as of Friday, May 29, 2026. This represents a 168.61% decrease compared to its 12-month average of -27.90%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.